| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And COO
1 company
Metzger Michael A is a Chief Executive Officer at Syndax Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $9.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | SNDX Syndax Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 6,847 | $18.99 | $130,024.53 | -1.4% | - | - | |
| Feb 9, 2026 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sell | 17,159 | $21.03 | $360,819.45 | -3.4% | +1.4% | - | |
| Sep 8, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 157,307 | $16.41 | $2,582,021.37 | -34.5% | +22.4% | - | |
| Jul 16, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sell | 7,534 | $9.29 | $69,953.19 | -2.5% | +65.5% | - | |
| Mar 4, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 7,814 | $15.05 | $117,563.97 | -2.5% | -23.6% | +50.3% | |
| Feb 10, 2025 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sell | 13,288 | $15.50 | $206,017.15 | -4.2% | -27.4% | +40.9% | |
| Feb 6, 2023 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 5,959 | $27.64 | $164,697.23 | -25.2% | -23.5% | -14.7% | |
| Oct 6, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 16,231 | $25.29 | $410,507.96 | -47.9% | -5.1% | -51.4% | |
| Oct 4, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 33,769 | $25.02 | $844,890.00 | -38.9% | +2.6% | -51.3% | |
| Jul 25, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 31,602 | $21.06 | $665,392.75 | -47.2% | +10.0% | +2.3% |